key: cord-1044251-5t1g55ir
authors: Prentice, Ralley E.; Al‐Ani, Aysha H.; Christensen, Britt
title: Letter: Covid‐19—re‐initiating clinical services for chronic gastrointestinal diseases. How and when? Authors' reply
date: 2020-09-20
journal: Aliment Pharmacol Ther
DOI: 10.1111/apt.16065
sha: af9c76088f86ff55dbada155db842d5e003f5ce4
doc_id: 1044251
cord_uid: 5t1g55ir

LINKED CONTENT This article is linked to Al‐Ani et al and Britton et al papers. To view these articles, visit https://doi.org/10.1111/apt.15779 and https://doi.org/10.1111/apt.16061

We thank Britton et al for their considered letter 1 to our recently published review of prevention and management of Covid-19 in inflammatory bowel disease (IBD) patients. 2 We commend their survey evaluating adherence with social distancing and shielding recommendations in addition to patient preferences for method of out-patient review among 195 patients with high-risk chronic gastroenterological conditions, including 33 with IBD. 1 In the re-initiation phase of the pandemic, we aim to re-commence services in a tailored manner taking into consideration the current evidence for the role of telemedicine in IBD care. The management of IBD patients from remote locations is clearly established as being safe, acceptable to patients, cost-effective and convenient. 3, 4 Additionally, electronic home monitoring tools for patients with IBD are feasible and highly accepted. 5 Overall, the use of electronic health (eHealth) technologies in IBD is associated with improved medication adherence, quality of life, and IBD-related knowledge, with reduced duration of disease relapse and activity. 6 The Covid-19 pandemic has effectively forced healthcare systems, practitioners and patients to adopt these tools as a means of minimising healthcare-related patient exposures, 7 

Letter: COVID-19 -re-initiating clinical services for chronic gastrointestinal diseases. How and when?

Review article: prevention, diagnosis and management of COVID-19 in the IBD patient

Videoconference clinics improve efficiency of inflammatory bowel disease care in a remote and rural setting

Integration of telemedicine into clinical gastroenterology and hepatology practice

Development and feasibility study of a telemedicine tool for all patients with IBD: MyIBDcoach

EHealth technologies in inflammatory bowel disease: a systematic review

Practical management of inflammatory bowel disease patients during the COVID-19 pandemic: expert commentary from the Gastroenterological Society of Australia Inflammatory Bowel Disease faculty

Telehealth in the context of COVID-19: changing perspectives in Australia, the United Kingdom, and the United States

Addressing equity in telemedicine for chronic disease management during the Covid-19 pandemic

Inflammatory bowel disease in the COVID-19 pandemic: the patients' perspective